Home > Products > Novel inhibitors

Dexpramipexole

  Cat. No.:  DC22372   Featured
Chemical Structure
104632-28-2
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 104632-28-2
Chemical Name: (R)-Pramipexole 2HCl
Synonyms: (R)-Pramipexole;(R)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine;R-(+)-Pramipexole;(R)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine Dihydrochloride;(R)-Pramipexole Dihydrochloride;R-(+)-Pramipexole Dihydrochloride;Pramipexole Related Compound D (25 mg) ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole);DexpraMipexole;(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;(R)-Pramipexole Dihy;(S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine;2,6-Benzothiazolediamine, 4,5, 6,7-tetrahydro-N6-propyl-, (6R)-;(6R)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole;(6R)-4,5,6,7-tetrahydro-N6-propylbenzothiazole-2,6-diamine;(R)-(+)-2-amino-4,5,6,7-tetrahydro-6-(n-propylamino)benzothiazole;(R)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine;KNS-760704;Pramipexole [USAN:INN];PraMipexole Related CoMpound D;(6R)-N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine;FASDKYOPVNHBLU-SSDOTTSWSA-N;2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (6R)-;MLS006011813;AS-56557;DEXPRAMIPEXOLE [USAN];(6R)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;104632-28-2;CS-1196;Q5268345;DB15130;Dexpramipexole [USAN:INN];EN300-123062;NS00008478;DEXPRAMIPEXOLE [WHO-DD];2,6-BENZOTHIAZOLEDIAMINE, 4,5,6,7-TETRAHYDRO-N6-PROPYL-, (R)-;BDBM50568780;UNII-WI638GUS96;(R)-Pramipexole;R-(+)-Pramipexole;KNS-760704;DTXSID50146624;AC-36724;HY-17355B;Dexpramipexole (USAN/INN);(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine;F19514;(R)-4,5,6,7-TETRAHYDRO-6-(PROPYLAMINO)-BENZOTHIAZOLE-2-AMINE;AKOS005555111;D09886;SMR004703492;CHEMBL249420;DEXPRAMIPEXOLE [INN];WI638GUS96;SCHEMBL74780;BCP12512;2-Amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole; 4,5,6,7-Tetrahydro-N6-propyl-2,6-Benzothiazolediamine;;Dexpramipexole;DA-62809;(6R)-N~6~-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;STK621530;(R)-PRAMIPEXOLE;DEXPRAMIPEXOLE DIHYDROCHLORIDE;(R)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine;2,6-BenzothiazolediaMine, 4,5, 6,7-tetrahydro-N6-propyl-, (6R)-
SMILES: NC1=NC(CC[C@@H](NCCC)C2)=C2S1
Formula: C10H17N3S
M.Wt: 211.32708
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively; also possesses low/insignificant affinity (500–10,000 nM) for the 5-HT1A, 5-HT1B, 5-HT1D, and α2-adrenergic receptors; used for treating Parkinson's disease (PD) and restless legs syndrome (RLS).Alzheimer's DiseasePhase 2 Clinical
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC74557 PREX-in1 PREX-in1 is a specific small-molecule inhibitor of P-Rex1 and P-Rex2 Rac-GEF activity with IC50 of 4.5 uM (P-Rex1 DHPH Rac-GEF activity) in liposome-based GEF assay, inhibits P-Rex1 and P-Rex2 through their catalytic DH domain.
DC74555 GYS32661 GYS32661 (GYS 32661) is a potent Rac inhibitor capable of inhibiting both Rac1 and Rac1b, inhibited activated Rac1 with IC50 of 1.18 uM in in vitro pull-down assays.
DC74540 MTX-3937 MTX-3937 is a small-molecule inhibitor targeting Siglec-9 (Sialic acid-binding immunoglobulin-type lectin-9), a member of the Siglec family of immunomodulatory receptors. Siglec-9 is primarily expressed on immune cells, such as myeloid cells and natural killer (NK) cells, and plays a role in regulating immune responses by transmitting inhibitory signals through its intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs).
DC74539 L557-0155 L557-0155 is a small molecule inhibitor of VSIG-8, prevents VSIG-8 binding to VISTA, promotes cytokine production and cell proliferation in PBMCs and suppresses melanoma growth.
DC74528 K284 K284 is a selective small molecule inhibitor of chitinase 3 like1 (CHI3L1) with strong binding affinity (Kd=-9.7 kcal·mol-1), inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
DC74225 YB-537 YB-537 (YB537) is a potent, highly specific quinone reductase 2 (QR2) inhibitor with IC50 of 3 nM, shows no activity against QR1 (IC50>10 uM).
DC74223 X-Neu5Ac X-Neu5Ac (sodium) is a substrate for chromogenic assay of neuraminidase activity in bacterial expression systems; with a Km of 0.89 mM for neuraminidase.
DC74218 UT-59 UT-59 is a specific inhibitor of cholesterol-sensing membrane protein Scap, binds to Scap's cholesterol-binding site, blocks SREBP activation and inhibits lipid synthesis.
DC74205 Tryptolinamide Tryptolinamide (TLAM) is a small-molecule compound that activates mitochondrial respiration in cybrids generated from patient-derived mitochondria and fibroblasts from patient-derived iPSCs, inhibits phosphofructokinase-1 (PFK1) with an ATP-uncompetitive
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia